Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
13.02.25
/
50%
€130.00
Target price
13.02.26
€163.54
Performance (%)
6.50%
End price
14.02.26
€138.45
Summary
This prediction ended on 14.02.26 with a price of €138.45. With a performance of 6.50%, the BUY prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc closed with a slight gain. Wells_Fargo___Compan has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Jazz Pharmaceuticals plc | 1.784% | 1.784% | 40.687% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $130.00.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€155.95
18.11.25
18.11.25
€202.73
18.11.26
18.11.26
2.44%
30.03.26
30.03.26
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€162.75
25.02.26
25.02.26
€212.10
25.02.27
25.02.27
-1.84%
30.03.26
30.03.26